IN THE UNITED STATES PATENT AND TRADEMARK OFFICE
`
`In Re:
`
`US. Patent of Bodo Asmussen et a1.
`
`Proceeding No.:
`
`IPR2015—00268
`
`Patent No.:
`
`6,335,031
`
`Application No.:
`
`09/291,498
`
`For:
`
`TTS CONTAINING AN ANTIOXIDANT
`
`PATENT OWNER’S POWER OF ATTORNEY IN AN INTER PARTES REVIEW
`
`Patent Owner Novartis AG (‘Novartis”) hereby appoints Raymond R. Mandra
`
`(Reg. No. 34,3 82) and Nicholas N. Kallas (Reg. No. 31,530) as its attorneys to prosecute the
`
`aforementioned proceeding and to transact all business in the United Patent and Trademark
`
`Office connected therewith.
`
`Please address all correspondence as follows:
`
`Raymond R. Mandra
`Fitzpatrick, Cella, Harper & Scinto
`1290 Avenue of the Americas
`
`New York, NY 101 04~3 800
`Telephone: (212) 218-2100
`Facimile: (212) 218—2200
`rmandra@fchs.com
`
`Dated: Novemberggjlom
`
`I
`
`-
`
`Andrea Jacquin
`Novartis Phannaceuticals Corporation
`One Health Plaza
`
`Dated: Nov mberpr, 014
`
`
`Novartis Pharmaceuticals Corporation
`One Health Plaza
`
`East Hanover, NJ 07936-1080
`
`East Hanover, NJ 07936-1080
`
`Witnessed by:
`
`'
`
`Witnessed by:
`
`.
`
`Sign
`
`Sign
`
`e
`
`,
`
`£23315;ng , Jujugég i; , Samar/2 ’25“
`C/flf/
`)l’lflurlt'l‘w ”‘63W]?! 663:
`
`Printe name
`
`Print d name
`
`

`

`(i NOVARTIS
`
`Power of Attorney
`(To Novartis [P colleagues based in US, UK, IT, DE, 86, CN)
`
`By this Power of Attorney, effective 01 January 2014, Novartis AG, a company
`incorporated under the laws of Switzerland and having its principal place of business at
`Lichtstrasse 3S, 4056 Basel, Switzerland (“the Company”), hereby grants to the Novartis
`Group Companies listed below (“the Corporate Signatories”):
`
`8)
`
`the revocable authority to sign documents on behalf of the Company in
`connection with filing, prosecution, maintenance, and administration of any
`intellectual
`property right
`for
`copyright, design, domain
`name,
`patent,
`supplementary protection certificate (SPC) and trademark registration or any
`application therefore standing in the name of the Company (“11’”);
`
`b)
`
`the revocable authority to sign documents on behalf of the Company in
`connection with litigation relating to defense of [P before a governmental
`authority; and
`
`the revocable authority to sign Confirmatory Assignments on behalf of the
`Company.
`“Confirmatory Assignments” are agreements between the Company
`and a third party or a Novartis Group entity that do not create new rights or
`obligations for the Company, such rights having been created by an underlying
`agreement (eg. acquisition/divestment agreement, research funding/collaboration
`agreement, and the like) and whereby the Confirmatory Assignment merely
`executes the transfer of IP as agreed in such underlying agreement;
`
`and for no other purposes.
`
`This Power of Attorney excludes the power to conclude contracts, other than
`Confirmatory Assignments, or to enter into settlements on behalf of the Company.
`The
`terms
`“contracts”
`and
`“settlements”
`include
`license
`agreements,
`acquisition/divestment agreements, assignments, prior right agreements and/0r letters of
`consent.
`
`This Power of Attorney includes the power to appoint external agents within the scope of
`this Power of Attorney.
`
`To be legally binding upon the Company, all relevant documents require the signature of
`two employees of the Corporate Signatory as set out below (“Personal Signatories”)
`authorized to sign for the respective Corporate Signatory, except where a single Personal
`Signatory is permitted according to the Novartis internal “Intellectual Property Signature
`Guidelines” .
`
`

`

`—-I-
`
`F‘Y'“:f
`
`Corporate Signatories
`
`Personal Signatories
`
`Alcon Laboratories, lnc.
`
`Alcon Research, Ltd.
`
`Novartis Healthcare Private Limited
`
`Catherine D. Murray
`Christianne K. Garrow
`Denise C. Vivar
`
`Mary Lozano
`Stephanie J. Boyle
`Sheldon R. Pontaoe
`
`Barbara McKenzie
`
`Barry L. Copeland
`Candace Sanders
`Christine Bohmann
`Christine Santelli
`Darden Weiss
`Darien L. Reddick
`Deborah Weinschenk
`Deena Nutt
`
`Gergely T. Zimanyi
`Glenda Wolfe
`
`Gregg C. Brown
`Jason .l. Derry
`Jian Zhou
`
`Jonathan E. Prejean
`Keiko Ichiye
`Kelly Bryant
`Kenneth D. Bassinger
`Mark E. Flanigan
`Martha J. Martin
`Michael Rein
`
`Patrick M. Ryan
`Robert Ambrose
`Russell E. Henrichs
`
`Matthew A. Hayenga
`Scott A. Chapple
`Sheldon R. Pontaoe
`
`Shelley Rose
`Sheng Hu
`Sue Stockton
`
`Tracy Humphreys
`W. David Lee
`
`Atul Bade
`
`Ashish Jogi
`
`Novartis Vaccines and Diagnostics GmbH
`
`Graham Wilkinson
`
`

`

`.1
`
`Corporate 'Signatories
`
`Personal Signatories
`
`Novartis Vaccines and Diagnostics, S.r.l.
`
`Sandoz International Gmbll
`
`Novartis Animal Health US, Inc.
`
`Novartis Consumer Health, Inc.
`
`Antoine Courgeon
`Stephen Evans
`Ilaria Ferrarini
`Marta Palla
`
`Andrea Felbermeir
`Britta Chamberlain
`Manuela Hillewaert
`Meike Urban
`Susanne Groeschel-Jofer
`
`Tanya Fickenscher—Leonard
`
`Delisa Daniels
`Todd Sladek
`
`Jennifer Story
`Clint Vranian
`
`Latonya Raston
`
`Alison Kessler
`Beth Nussbaum
`Diane Furman
`
`Greg Tole
`Mary Cheli
`Mary Leheny
`Nazuki Hughes
`Maria Stachura
`
`Novartis Vaccines and Diagnostics, Inc.
`
`Alishia Collins Rowe—Babb
`
`Amy Hessler
`Amy Olinger
`Beth O'Brien
`
`Christy Snyder
`David Carpenter
`Helen Lee
`Joanna Burns
`John Ward
`
`Juerg Baenziger
`Kenneth M. Goldman
`Lisa Alexander
`Lisa Nash
`
`Mei Hong
`Michael G. Smith
`Marco Riensche
`Nick Finnie
`Norma Gallina
`
`Regina Bautista
`
`

`

`Corporate Signatories
`
`Personal Signatories
`
`Novartis Corporation
`
`Betty Ryberg
`
`Novartis Institutes for BioMedical Research,
`Inc.
`
`Novartis Institute for Functional Genomics,
`Inc.
`
`CIBA VISION Vertriebs GmbH
`
`Alvin Fitzgerald
`Arlene Musser
`Frank Wu
`
`.Iasbir Sagoo
`Jean Silveri
`.IilI Clarke
`John B. Alexander
`John Prince
`Joshua Roth
`Karen Lacourse
`Laura Madden
`Leslie Gould
`Matthew Beaudet
`Mei Benni
`Melissa Ponziano
`
`Paul Paglierani
`Qian Zhang (Andy) [iKfiE]
`Scott Brown
`Scott Reid
`
`Sophie Binet Cross
`Susan Dillon
`
`Chihang Amy Smith
`Daniel E. Raymond
`Emily Tongco-Wu
`Kerri Pollard Schray
`Lisa Watts
`Susan Sesnovich
`
`Timothy L. Smith
`
`Frank Kaul
`Frank Hauerken
`Jan-There Fohrenbach
`
`
`
`

`

`Corporate Signatories
`
`Personal Signatories
`
`Novartis Pharmaceuticals Corporation
`
`If1""
`
`Andrea Jacquin
`Andrew Holmes
`Annette Cromer
`Carmella O’Gorman
`Christine MeCormack
`
`Cindy Klepacky
`Cozette McAvoy
`Daniel Woods
`
`David Kurlandsky
`Denise Cooper
`Diane Leone
`
`Gregory Ferraro
`Gregory Houghton
`Jennifer Chapman
`Jim Lynch
`John Li
`Karen Zielen
`
`Kelly Stritenberger
`Leslie Fischer
`Linda Adams
`Lisa Matovcik
`
`Lourdes Campos Cruz
`Lydia McNally
`Marie Collazo
`Mark Seka
`Matthew Mulkeen
`Maureen McGee
`
`Mehdi Ganjeizadeh
`Michael Mazza
`Peter Waibel
`Sandra Rueck
`Sherri Rose
`
`Sudipta Rao
`Svetlana Korzhin
`
`

`

`v—
`".—
`
`1/1,7
`
`
`
`Corporate Signatories Personal Signatories
`
`Novartis Pharmaceuticals UK Limited
`
`Alex Bone
`
`Craig McLean
`Daniela Deriu
`
`Emma Hodge
`Natalie Osmond
`Nicki Hiller
`Peter Graham Stuart
`
`Philippe Mueller
`Robert Poolman
`
`Novartis Institute for Tropical Diseases Pte.
`Ltd.
`
`Younbeen Kim
`
`Beijing Novartis Pharma Co. Ltd.
`
`Fan (Kent) Yang [lama]
`Zheng (Aileen) Wei [flfi’rl
`Wen (Lucia) Tang [$313]
`Juan (Jane) Ye [H95]
`Xiaoning (Remy) Wang [I/N‘F]
`
`Novartis Services Incorporated
`
`Frank Smith
`
`This Power-of—Attomey is valid until 3i December 2014 and replaces all previous
`versions of Powers of Attorney relating to the subject matter herein.
`
`Basel, 04 December 2013,
`
`NOVARTIS AG
`
`(7
`
`MW
`
`___________________________________________________________:14’
`
`El kl
`
`”J
`
`Authorized Signatory
`
`Authorized Signatory
`
`Alisa Harbin
`Authorized Signatory
`
`Ian James Hiscock
`Authorized Signatory
`
`

`

`F_r
`
`ATTESTATION
`
`I, the undersigned Civil Law Notary in Basel, Switzerland, Dr. Matthias Staehelin, certify
`
`herewith that
`
`the signatures attached heretofore are the genuine signatures of Ms.
`
`Alisa Harbin, citizen of
`
`the United States of America,
`
`residing in Reinach BL,
`
`Switzerland; and of Mr. Ian James Hiscock, British citizen,
`
`residing in Gempen,
`
`Switzerland; both acting for Novartis AG,
`
`in Basel, Switzerland, both as authorized
`
`signatories and both with joint signature.
`
`The authenticity of the signatures was established by means of comparison.
`
`BASEL, Switzerland, this 9th (ninth) day of December 2013 (two thousand and thirteen)
`
`‘9
`
`\ \
`
`\
`\\
`\
`
`Leg.Prot.Nr. 2t "lib/2013
`
`

`

`IN THE UNITED STATES PATENT AND TRADEMARK OFFICE
`
`In Re:
`
`US. Patent of Bodo Asmussen er a1.
`
`Proceeding N0.:
`
`IPR2015-00268
`
`Patent N0.:
`
`6,335,031
`
`Application N0.:
`
`09/291,498
`
`For:
`
`TTS CONTAINING AN ANTIOXIDANT
`
`PATENT OWNER’S POWER OF ATTORNEY IN AN INTER PARTES REVIEW
`
`Patent Owner LTS Lohmann Therapie—Systeme AG (“LTS”) hereby appoints
`
`Raymond R. Mandra (Reg. No. 34,382) and Nicholas N. Kallas (Reg. No. 31,530) as its
`
`attorneys to prosecute the aforementioned proceeding and to transact all business in the United
`
`Patent and Trademark Office connected therewith.
`
`Please address all correSpondence as follows:
`
`Raymond R. Mandra
`Fitzpatrick, Cella, Harper & Scinto
`1290 Avenue ofthe Americas
`
`New York, NY 10104—3 800
`
`Telephone: (212) 218—2100
`Facimile: (212) 218-2200
`rmandra@fchs.com
`
`By: 447/1.m l
`
`
`
`i“ ‘36 /&’_’/M «—r
`
`Ulrich Sielaff WDr. Bernd Gillines
`General Counsel
`/ Patent Counsel
`LTS Lohmann Therapie-Systeme AG
`Lohmannstrafle 2
`D-56626 Andernaoh
`GERMANY
`
`Date: Novemberzé, 2014
`
`FCHS_WS 10859561v1.doc
`
`